Literature DB >> 25088001

Therapeutic effects of mesenchymal stem cell-derived microvesicles on pulmonary arterial hypertension in rats.

Jian-ying Chen1, Ran An1, Zhen-jun Liu1, Jin-ju Wang2, Shu-zhen Chen2, Mian-ming Hong1, Jing-hu Liu1, Meng-yuan Xiao1, Yan-fang Chen2.   

Abstract

AIM: Microvesicles (MVs) are nanoscale membrane fragments released from virtually all cell types upon activation or apoptosis, and may contribute to the beneficial effects of stem cell therapy. In this study, we investigated the therapeutic effects of mesenchymal stem cell (MSC) derived MVs (MSC-MVs) on pulmonary artery hypertension (PAH) in rats.
METHODS: MSC-MVs were isolated from rat bone marrow MSCs that were cultured in a serum-free conditioned medium. Transmission electron microscopy (TEM), flow cytometry and nanoparticle tracking analysis (NTA) were used to characterize the MVs. Adult SD rats were injected with monocrotaline (50 mg/kg, sc) to induce PAH. Three weeks later, the rats were intravenously injected with MSCs, MSC-MVs or saline for 2 weeks. At the end of treatments, the hemodynamic parameters and pathological right ventricular and pulmonary arterial remodeling were analyzed in each group.
RESULTS: The MSC-MVs showed general morphologic characteristics of MVs and expressed annexin V and CD29 markers under TEM, and their size ranged from 40 to 300 nm. Intravenous injection of MSC-MVs or MSCs significantly ameliorated the mean pulmonary artery pressure (mPAP) and mean right ventricle pressure (mRVP) in PAH rats. Furthermore, intravenous injection of MSC-MVs or MSCs significantly decreased the right ventricle (RV) hypertrophy and pulmonary arteriole area index (AI) and thickness index (TI) in PAH rats.
CONCLUSION: Intravenous injection of MSC-MVs or MSCs produces similar beneficial effects for treating PAH, and our results provide a basis for cell-free approach in stem cell therapy.

Entities:  

Mesh:

Year:  2014        PMID: 25088001      PMCID: PMC4155533          DOI: 10.1038/aps.2014.61

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  30 in total

Review 1.  Pulmonary arterial hypertension.

Authors:  Harrison W Farber; Joseph Loscalzo
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

2.  Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.

Authors:  Elena I Sinauridze; Dmitry A Kireev; Nadezhda Y Popenko; Aleksei V Pichugin; Mikhail A Panteleev; Olga V Krymskaya; Fazoil I Ataullakhanov
Journal:  Thromb Haemost       Date:  2007-03       Impact factor: 5.249

3.  Mesenchymal stem cells attenuate vascular remodeling in monocrotaline-induced pulmonary hypertension rats.

Authors:  Jiang Xie; Dayi Hu; Lili Niu; Suping Qu; Shenghao Wang; Shuang Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

4.  Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.

Authors:  Stefano Gatti; Stefania Bruno; Maria Chiara Deregibus; Andrea Sordi; Vincenzo Cantaluppi; Ciro Tetta; Giovanni Camussi
Journal:  Nephrol Dial Transplant       Date:  2011-02-15       Impact factor: 5.992

5.  Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.

Authors:  Yidan D Zhao; David W Courtman; Yupu Deng; Lakshmi Kugathasan; Qiuwang Zhang; Duncan J Stewart
Journal:  Circ Res       Date:  2005-02-03       Impact factor: 17.367

6.  Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.

Authors:  Soban Umar; Yvonne P de Visser; Paul Steendijk; Cindy I Schutte; El Houari Laghmani; Gerry T M Wagenaar; Wilhelmina H Bax; Eleni Mantikou; Daniel A Pijnappels; Douwe E Atsma; Martin J Schalij; Ernst E van der Wall; Arnoud van der Laarse
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-25       Impact factor: 4.733

7.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

8.  Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension.

Authors:  Changjin Lee; S Alex Mitsialis; Muhammad Aslam; Sally H Vitali; Eleni Vergadi; Georgios Konstantinou; Konstantinos Sdrimas; Angeles Fernandez-Gonzalez; Stella Kourembanas
Journal:  Circulation       Date:  2012-10-31       Impact factor: 29.690

9.  MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles.

Authors:  Hongqi Xin; Yi Li; Zhongwu Liu; Xinli Wang; Xia Shang; Yisheng Cui; Zheng Gang Zhang; Michael Chopp
Journal:  Stem Cells       Date:  2013-12       Impact factor: 6.277

10.  Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes.

Authors:  Olivier G de Jong; Marianne C Verhaar; Yong Chen; Pieter Vader; Hendrik Gremmels; George Posthuma; Raymond M Schiffelers; Marjan Gucek; Bas W M van Balkom
Journal:  J Extracell Vesicles       Date:  2012-04-16
View more
  30 in total

Review 1.  Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities.

Authors:  Ali Hassanzadeh; Heshu Sulaiman Rahman; Alexander Markov; Judi Januadi Endjun; Angelina Olegovna Zekiy; Max Stanley Chartrand; Nasrin Beheshtkhoo; Mohammad Amin Jadidi Kouhbanani; Faroogh Marofi; Marzieh Nikoo; Mostafa Jarahian
Journal:  Stem Cell Res Ther       Date:  2021-05-21       Impact factor: 6.832

Review 2.  Mesenchymal Stem Cell (MSC)-Derived Extracellular Vesicles: Potential Therapeutics as MSC Trophic Mediators in Regenerative Medicine.

Authors:  Qi-Ling Yuan; Yin-Gang Zhang; Qian Chen
Journal:  Anat Rec (Hoboken)       Date:  2019-06-17       Impact factor: 2.064

Review 3.  Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease.

Authors:  Airan Liu; Xiwen Zhang; Hongli He; Li Zhou; Yoshifumi Naito; Shinji Sugita; Jae-Woo Lee
Journal:  Expert Opin Biol Ther       Date:  2019-11-18       Impact factor: 4.388

Review 4.  Mesenchymal stem cells in the pathogenesis and treatment of bronchopulmonary dysplasia: a clinical review.

Authors:  Ann A Simones; Daniel J Beisang; Angela Panoskaltsis-Mortari; Kari D Roberts
Journal:  Pediatr Res       Date:  2017-10-25       Impact factor: 3.756

Review 5.  Exosomes: new molecular targets of diseases.

Authors:  Saheli Samanta; Sheeja Rajasingh; Nicholas Drosos; Zhigang Zhou; Buddhadeb Dawn; Johnson Rajasingh
Journal:  Acta Pharmacol Sin       Date:  2017-12-07       Impact factor: 6.150

Review 6.  Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.

Authors:  Antoine Monsel; Ying-Gang Zhu; Varun Gudapati; Hyungsun Lim; Jae W Lee
Journal:  Expert Opin Biol Ther       Date:  2016-04-12       Impact factor: 4.388

Review 7.  Extracellular vesicle-mediated bidirectional communication between heart and other organs.

Authors:  Khatia Gabisonia; Mohsin Khan; Fabio A Recchia
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-18       Impact factor: 4.733

Review 8.  Stem-cell extracellular vesicles and lung repair.

Authors:  Fernanda F Cruz; Patricia R M Rocco
Journal:  Stem Cell Investig       Date:  2017-09-21

9.  Endothelial Extracellular Vesicles in Pulmonary Function and Disease.

Authors:  Eleftheria Letsiou; Natalie Bauer
Journal:  Curr Top Membr       Date:  2018-10-08       Impact factor: 3.049

10.  Analyses of Endothelial Cells and Endothelial Progenitor Cells Released Microvesicles by Using Microbead and Q-dot Based Nanoparticle Tracking Analysis.

Authors:  Jinju Wang; Yun Zhong; Xiaotang Ma; Xiang Xiao; Chuanfang Cheng; Yusen Chen; Ifeanyi Iwuchukwu; Kenneth J Gaines; Bin Zhao; Shiming Liu; Jeffrey B Travers; Ji C Bihl; Yanfang Chen
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.